Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

CVS HEALTH (CVS)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summary4-Traders Strategies
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • The company has solid fundamentals for a short-term investment strategy.
Strengths
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.55 for the 2017 fiscal year.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
  • The technical configuration over the long term remains negative on the weekly chart below the resistance level at 77.97 USD
Ratings chart
Sector Drug Retailers - NEC
1st jan.Capitalisation (M$)Investor Rating
CVS HEALTH-5.42%75 327
WALGREENS BOOTS ALLIANCE-18.15%72 488
EXPRESS SCRIPTS HOLDING CO-16.02%33 365
MCKESSON CORPORATION6.77%30 742
CARDINAL HEALTH INC-10.10%20 394
AMERISOURCEBERGEN CORP.5.13%17 636
JOINTOWN PHARMACEUTICAL GRO..3.71%5 414
MEDIPAL HOLDINGS CORP17.19%4 564
CHINA NATIONAL ACCORD MEDIC..--.--%4 218
MATSUMOTOKIYOSHI HOLDINGS C..43.92%3 968
WELCIA HOLDINGS CO LTD20.17%3 917
SUZUKEN CO., LTD.6.94%3 679
JEAN COUTU GROUP PJC INC16.55%3 596
CHINA NATIONAL MEDICINES CO..0.10%3 513
REALCAN PHARMACEUTICAL CO L..--.--%3 503
CLICKS GROUP LTD31.37%2 884
More Results
Financials ($)
Sales 2017 184 B
EBIT 2017 10 051 M
Net income 2017 5 266 M
Debt 2017 24 750 M
Yield 2017 2,61%
P/E ratio 2017 14,75
P/E ratio 2018 12,82
EV / Sales 2017 0,55x
EV / Sales 2018 0,52x
Capitalization 75 866 M
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart CVS HEALTH
Duration : Period : Day
CVS Health Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Duration : Period : Week
CVS Health Technical Analysis Chart | CVS | US1266501006 | 4-Traders